Clinical trial
A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation
NCT00429039 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Terminated
Key facts
| NCT number | NCT00429039 |
|---|---|
| Title | A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation |
| Official title | LLME Treated Cellular Immunotherapy Following T-cell Depleted Allogeneic Heamtopoietic Stem Cell Transplantation for Acceleration of Immune Reconstitution |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| Intervention type | Drug |
| Interventions | L-leucyl-L-leucine methyl ester (LLME) |
| Enrollment | 21 |
| Start date | Sep 1, 2000 |
| Primary completion | Oct 1, 2007 |
| Completion | Aug 1, 2009 |
| First posted | Jan 31, 2007 |
| Last update posted | Oct 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: